Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastases-Reference-Cited by-同舟云学术

Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastases

Published:2007-09-28 Issue:2 Volume:62 Page:195-201
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Ychou M.,Viret F.,Kramar A.,Desseigne F.,Mitry E.,Guimbaud R.,Delpero J. R.,Rivoire M.,Quénet F.,Portier G.,Nordlinger B.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-007-0588-3.pdf

Reference24 articles.

1. Bengmark S, Hafstrom L (1969) The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer 23:198–202

2. Welch JP, Donaldson GA (1979) The clinical correlation of an autopsy study of recurrent colorectal cancer. Ann Surg 189:496–500

3. Weiss L, Grundmann E, Torhorst J et al (1986) Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1,541 necropsies. J Pathol 150:195–203

4. Zadavski KE, Lee YTM (1994) Liver metastases from colorectal carcinoma: incidence, resectability and survival results. Ann Surg 60:929–932

5. Hughes KS, Simon R, Songhorabodi S et al (1986) Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery 100:278–284

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Triplet chemotherapy with or without bevacizumab as first line treatment for metastatic colorectal cancer: An AGEO multicenter real-world study;Digestive and Liver Disease;2024-09

2. Regorafenib plus FOLFIRINOX as first-line treatment for patients with RAS-mutant metastatic colorectal cancer (FOLFIRINOX-R trial): a dose-escalation study;Cancer Chemotherapy and Pharmacology;2024-07-10

3. Efficacy and quality of life for FOLFOX/bevacizumab +/− irinotecan in first-line metastatic colorectal cancer—final results of the AIO CHARTA trial;British Journal of Cancer;2023-11-23

4. CD44 mediated colon cancer targeting mutlifaceted lignin nanoparticles: Synthesis, in vitro characterization and in vivo efficacy studies;International Journal of Pharmaceutics;2023-08

5. Successful Combined Treatment of a Patient with Borderline Resectable Liver Metastasis of Colorectal Cancer;Russian Journal of Gastroenterology, Hepatology, Coloproctology;2022-12-30